Skip to main content
Fig. 3 | BMC Medical Genomics

Fig. 3

From: Pancancer analysis of the prognostic and immunological role of FANCD2: a potential target for carcinogenesis and survival

Fig. 3

Association between FANCD2 expression and the OS of cancer patients. A A forest plot displaying hazard ratios of FANCD2 in 33 types of tumors. B Kaplan-Meier survival curves illustrating the OS of patients categorized by the varying expressions of FANCD2 in BRCA, KIRC, KIRP, LIHC, LUAD, OV, PAAD, PCPG, SARC, and UCEC. *P < 0.05, **P < 0.01, and ***P < 0.001

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us